Editorial: Personalized immunotherapy for cancer
- PMID: 36959783
- PMCID: PMC10028269
- DOI: 10.3389/fonc.2023.1171907
Editorial: Personalized immunotherapy for cancer
Keywords: T cell; adoptive cell immunotherapy; cancer immunotherapies; checkpoint blockade immunotherapy; personalized medicine.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Personalized immunotherapy for cancer
Publication types
LinkOut - more resources
Full Text Sources